NVDA
52
-3
MU
34
3
DIS
60
2
BBY
56
-2
BWA
45
-4
LYB
46
-4
IR
72
-5
MLM
53
-5
SCHW
52
3
HSIC
50
-3
ALLE
57
-7
DOV
64
-5
CFG
38
-2
EOG
42
-8
MCO
80
2
DUK
64
2
AEP
58
2
ADM
33
-3
PEG
76
5
L
55
-4
NVDA
52
-3
MU
34
3
DIS
60
2
BBY
56
-2
BWA
45
-4
LYB
46
-4
IR
72
-5
MLM
53
-5
SCHW
52
3
HSIC
50
-3
ALLE
57
-7
DOV
64
-5
CFG
38
-2
EOG
42
-8
MCO
80
2
DUK
64
2
AEP
58
2
ADM
33
-3
PEG
76
5
L
55
-4
Financhill
Back

Centrais Eletricas Brasileiras SA Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
60

EBR
Centrais Eletricas Brasileiras SA

Last Price:
7.28
Seasonality Move:
-0.03%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
60
Centrais Eletricas Brasileiras SA (EBR) is a Buy

Is Centrais Eletricas Brasileiras SA a Buy, Sell or Hold?

  • The current Centrais Eletricas Brasileiras SA [EBR] share price is $7.26. The Score for EBR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • EBR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

EBR Stock Price Chart

What is Centrais Eletricas Brasileiras SA's stock price today?

  • The Centrais Eletricas Brasileiras SA share price today is $7.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EBR is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

EBR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 43.34 Sell
Chaikin Money Flow: -893996 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.42 - 7.66) Sell
Bollinger Bands (100): (6.69 - 7.53) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

EBR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 7.54 Sell
50-day SMA: 7.24 Buy
200-day SMA: 7.74 Sell
8-day EMA: 7.53 Sell
20-day EMA: 7.49 Sell
50-day EMA: 7.33 Sell
200-day EMA: 7.46 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Centrais Eletricas Brasileiras SA Earnings Growth & EBR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.35 per share, and a decrease next year of $0.13 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Centrais Eletricas Brasileiras SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):